INTRODUCTION
Neuroblastoma (NB) is one of the most common solid abdominal malignant tumors in children. It can occur anywhere along the sympathetic nervous system, accounting for approximately 6%–10% of all tumors in children with a mortality rate of 15% and seriously threatening children’s life and health.1 Although current therapeutic approaches for NB include surgery, chemotherapy and radiotherapy combined with comprehensive treatment, which improve prognosis for patients, their effect remains poor, with a high risk of recurrence2 due to its diverse biological behavior. However, surgery is still an important part of the treatment of NB, and its safety cannot be ignored. NB has been staged with a gradual improvement from the International Neuroblastoma Staging System (INSS) to the international neuroblastoma risk group (INRG) in recent years.3 Abdominal NB in children is often large and easily invades surrounding tissues and blood vessels, resulting in high surgical difficulty and risk of postsurgical complications. Therefore, preoperative imaging assessment of surgical risk is very important for the prognosis of these children.
In recent years, image-defined risk factors (IDRFs) in the International Neuroblastoma risk Classification Group (INRG) have often been used as evaluation indicators4 to predict the risk of complications associated with tumor resection. The stratified risk assessment was carried out by preoperative imaging assessment including tumor location, whether the tumor invaded important blood vessels or organs and whether it entered the spinal canal and other indicators, which suggests that the incidence of surgical complications in IDRF-positive children was much higher than that in IDRF-negative children.5–7 Although IDRFs currently play the main role in the evaluation of surgical risk in NB, there are subjective interpretation errors. Only semiquantitative image information can be used to evaluate the structural characteristics of tumors, and there is no distinction between low-risk, medium-risk, and high-risk NB, which lacks the information needed for personalized biology and targeted therapy. It also fails to provide the molecular and gene-level biological information needed for precision medicine.
With the advent of the era of artificial intelligence and big data, radiomics, as an emerging technique, has been increasingly proved to have clinical significance. It can capture automated quantitative analysis of phenotypic information through a data representation algorithm and extract meaningful imaging features from quantitative analysis of visual medical images. Machine learning models for prediction can be established using these features,8 which can further play a role in guidance and prediction in clinical practice. At present, a number of studies on adults have reported that the pathological classification and grading of tumors9–13 and prognosis can be predicted before surgery by extracting radiomic features from medical images of abdominal malignant tumors and using machine learning for in-depth analysis. This study aimed to develop and validate a radiomics-based machine learning model based on the analysis of radiomics features to predict surgical risk in children with abdominal NB.